Molecular characterization of ciprofloxacin resistance of gonococcal strains in Spain

被引:22
作者
Alcalá, B
Arreaza, L
Salcedo, C
Antolín, I
Borrell, N
Cacho, J
De Las Cuevas, C
Otero, L
Sauca, G
Vázquez, F
Villar, H
Vázquez, JA [1 ]
机构
[1] Inst Salud Carlos III, Serv Bacteriol, Lab Referencia Neisserias, Ctr Nacl Microbiol, Madrid 28220, Spain
[2] Hosp San Agustin, Asturias, Spain
[3] Fac Med, Asturias, Spain
[4] Hosp Monte Naranco, Asturias, Spain
[5] Hosp de Mataro, Barcelona, Spain
[6] Hosp Cabuenes, Asturias, Spain
[7] Hosp Univ Princesa, Madrid, Spain
[8] Hosp Univ Getafe, Madrid, Spain
[9] Hosp Son Dureta, Palma de Mallorca, Spain
[10] Hosp Princesa Sofia, Leon, Spain
关键词
D O I
10.1097/00007435-200305000-00004
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background: Over the past several years, the emergence of gonococcal isolates with intermediate or full resistance to fluoroquinolones has become a significant concern in several countries, including Spain. Goal. The goal was to determine the occurrence of ciprofloxacin resistance among Neisseria gonorrhoeae strains in Spain during 2000 to 2001 and determine the frequency and patterns of mutations at gyrA, gyrB, and parC genes in these isolates. Study Design: Eleven ciprofloxacin-resistant strains (with MICs ranging from 1 to 64 mug/mL) and two intermediate isolates (with MICs of 0.12 and 0.5 mug/mL) were found. Mutations were identified by polymerase chain reaction and direct sequencing of the amplified products. Results and Conclusions: Alterations at Ser-91 and Asp-95 in GyrA were detected in all strains except one, an isolate for which the MIC was 0.12 mug/mL. Alterations in ParC were more variable, and there was no clear correlation between the number of parC mutations and the level of resistance. No alterations at gyrB gene associated with ciprofloxacin resistance were found. The resistance was distributed among different types of strains, suggesting that the increase in the incidence of ciprofloxacin-resistant strains in Spain was not exclusively due to the appearance of a single-strain outbreak.
引用
收藏
页码:395 / 398
页数:4
相关论文
共 27 条
  • [1] [Anonymous], 2002, M100S12 NCCLS
  • [2] NEISSERIA-GONORRHOEAE ACQUIRES MUTATIONS IN ANALOGOUS REGIONS OF GYRA AND PARC IN FLUOROQUINOLONE-RESISTANT ISOLATES
    BELLAND, RJ
    MORRISON, SG
    ISON, C
    HUANG, WM
    [J]. MOLECULAR MICROBIOLOGY, 1994, 14 (02) : 371 - 380
  • [3] In vitro susceptibilities of 400 Spanish isolates of Neisseria gonorrhoeae to gemifloxacin and 11 other antimicrobial agents
    Berrón, S
    Vázquez, JA
    Giménez, MJ
    de la Fuente, L
    Aguilar, L
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (09) : 2543 - 2544
  • [4] BYGDEMAN SM, 1988, IMMUNOLOGICAL DIAGNO, P123
  • [5] *CDCP, 1998, MMWR MORBID MORTAL W, V47
  • [6] Uncommon occurrence of mutations in the gyrB gene associated with quinolone resistance in clinical isolates of Neisseria gonorrhoeae
    Deguchi, T
    Yasuda, M
    Nakano, M
    Ozeki, S
    Kanematsu, E
    Kawada, Y
    Ezaki, T
    Saito, I
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (10) : 2437 - 2438
  • [7] DNA GYRASE MUTATIONS IN QUINOLONE-RESISTANT CLINICAL ISOLATES OF NEISSERIA-GONORRHOEAE
    DEGUCHI, T
    YASUDA, M
    ASANO, M
    TADA, K
    IWATA, H
    KOMEDA, H
    EZAKI, T
    SAITO, I
    KAWADA, Y
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (02) : 561 - 563
  • [8] Quinolone-resistant Neisseria gonorrhoeae: Correlation of alterations in the GyrA subunit of DNA gyrase and the ParC subunit of topoisomerase IV with antimicrobial susceptibility profiles
    Deguchi, T
    Yasuda, M
    Nakano, M
    Ozeki, S
    Ezaki, T
    Saito, I
    Kawada, Y
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (04) : 1020 - 1023
  • [9] ANALYSIS OF GENETIC-VARIABILITY OF PENICILLINASE NONPRODUCING NEISSERIA-GONORRHOEAE STRAINS WITH DIFFERENT LEVELS OF RESISTANCE TO PENICILLIN
    DELAFUENTE, L
    VAZQUEZ, JA
    [J]. JOURNAL OF MEDICAL MICROBIOLOGY, 1992, 37 (02) : 96 - 99
  • [10] Gonococcal resistance to β-lactams and tetracycline involves mutation in loop 3 of the porin encoded at the penB locus
    Gill, MJ
    Simjee, S
    Al-Hattawi, K
    Robertson, BD
    Easmon, CSF
    Ison, CA
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (11) : 2799 - 2803